Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514
Name: Drug, bio-affecting and body treating compositions >
Description: Class 514 is an integral part of Class 424. It incorporates all the definitions and rules as to subject matter of Class 424.










Class Number Class Name No. of Patents
514/810

Addiction

103
514/811

Alcohol

157
514/812

Narcotic

155
514/813

Tobacco

134
514/805

Adrenocorticotropic hormone or derivatives

32
514/814

Anemia

113
514/815

Sickle cell

44
514/816

Anesthetic, general

110
514/818

Anesthetic, local

120
514/817

Anesthetic, topical

147
514/819

Antacid, oral

87
514/820

With antiflatulent

21
514/821

Antiarrhythmic

427
514/822

Anticoagulation

476
514/823

Antidote

89
514/824

Arteriosclerosis

630
514/825

Arthritis

719
514/826

Asthma

843
514/827

Astringent, nonfacial

24
514/828

Topical for the skin

81
514/829

Bite or sting

42
514/831

Animal (nonpoisonous)

7
514/830

Insect

41
514/833

Blood plasma extender

88
514/832

Blood substitute

179
514/959

Breathing gases

53
514/808

Calcitonin or derivatives

63
514/962

Capsule (e.g., gelatin, etc.)

314
514/963

Microcapsule-sustained or differential release

332
514/835

Caries

101
514/975

Characterized by the designated surfactant used

371
514/836

Chelate

231
514/837

Cholera

21
514/838

Cirrhosis

38
514/834

Coagulant

79
514/801

Collagen, gelatin or derivatives thereof

217
514/839

Contact lens treatment

126
514/840

Chemical sterilizing

121
514/974

Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.)

269
514/970

Containing designated ingredient to stabilize an active ingredient

516
514/971

Crystallization point depressant or cold stabilizer containing

49
514/973

Sulfur compound additive as stabilizer (e.g., sulfites, etc.)

70
514/972

Ultraviolet light stabilizer containing

94
514/841

Contraceptive

148
514/843

Female (mammal)

245
514/842

Non-mammal

17
514/844

Cosmetic, facial

1426
514/846

Cleansing cream or lotion

618
514/848

Facial astringent

127
514/847

Facial moisturizer

713
514/845

Liquid make-up

298
514/849

Cough and cold preparation

128
514/850

Antitussive

52
514/851

Cystic fibrosis

126
514/852

Dandruff

121
514/853

Decongestant

66
514/855

Expectorant

41
514/854

Vasoconstrictor

18
 

Dermatitis

 
514/859

Acne

600
514/858

Athlete's foot

80
514/860

Cellulitis

66
514/865

Diaper rash

88
514/861

Eczema

304
514/862

Poison (ivy, oak, sumac)

82
514/863

Psoriasis

580
514/864

Seborrhea

222
514/769

Designated inorganic nonactive ingredient or elemental material other than water

191
514/771

Oxygen gas containing

27
514/770

Siliceous or calcareous material (e.g., clay, earth, etc.)

337
514/1

Designated organic active ingredient containing (doai)

691
 

Designated organic active ingredient containing (doai)

 
514/152

3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai

329
514/154

With an additional active ingredient (excludes reaction product or complex)

87
514/153

With stabilizer or preservative

29
514/167

9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai

707
514/168

With a vitamin type active ingredient

192
514/150

Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai

288
514/151

Acyclic c-n=n-n containing

123
514/693

Aldehyde doai

172
514/699

Benzene ring containing

98
514/701

Acyclic carbon to carbon unsaturation

37
514/700

Polycyclo ring system

46
514/703

Carbon to carbon unsaturation

121
514/694

Formaldehyde

50
514/696

With alcohol

19
514/697

With nitrogen containing compound

12
514/695

With polycyclo compound

4
514/704

Nitrogen containing

14
514/705

Plural c=o groups

89
514/702

Sulfur containing

27
514/698

With preservative or stabilizer

41
514/149

Azoxy doai

54
514/64

Boron containing doai

255
514/724

C-o-group (e.g., alcohol, alcoholate, etc.) doai

587
514/729

Alicyclic ring containing

321
514/730

Benzene ring containing

227
514/731

C of c-o- group is nuclear c of a benzene ring (e.g., phenol, phenolate, etc.)

404
514/733

Acyclic carbon to carbon unsaturation

123
514/736

Additional benzene ring containing

100
514/737

Nuclear halogenated

67
514/732

Polycyclo ring system (e.g., naphthols, etc.)

149
514/734

Two or more separate aryl-o-groups

126
514/735

Nuclear halogenated

32
514/739

Carbon to carbon unsaturated

225
514/726

Diphenyl-substituted acyclic alcohol or alcoholate

47
514/727

Nitrogen containing

142
514/728

C of c-o- group is nuclear c of a benzene ring (e.g., phenol, phenolate, etc.)

96
514/738

Polyhydroxy

372
514/725

Vitamin a compound or derivative

590
514/23

Carbohydrate (i.e., saccharide radical containing) doai

1811
514/53

Dissacharide

789
514/62

Glucosamine or derivative

474
514/42

N-glycoside

401
514/43

Nitrogen containing hetero ring

630
514/52

Phosphorus containing (e.g., vitamin b12, etc.)

329
514/44

Polynucleotide (e.g., rna, dna, etc.)

3242
514/45

Purines (including hydrogenated) (e.g., adenine, guanine, etc.)

653
514/46

Adenosine or derivative

773
514/47

Phosphorus containing

461
514/48

Phosphorus containing

277
514/49

Pyrimidines (including hydrogenated) (e.g., cytosine, etc.)

687
514/50

2,4-diketone pyrimidine or derivative (e.g., uracil, etc.)

623
514/51

Phosphorus containing

340
514/25

O-glycoside

1446
514/26

Cyclopentanohydrophenanthrene ring system

313
514/35

Oxygen of the saccharide radical bonded directly to a cyclohexyl ring

175
514/36

Two or more nitrogen atoms bonded directly to the cyclohexyl ring

105
514/37

The nitrogen atoms are in n-c(=n)-n groups (e.g., streptomycin, etc.)

94
514/40

Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring

137
514/41

Kanamycin or derivative

94
514/38

Two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring

58
514/39

Three or more saccharide radicals (e.g., neomycin, etc.)

134
514/27

Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring

537
514/28

The hetero ring has 8 or more ring carbons

174
514/31

The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)

192
514/29

The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)

518
514/30

The hetero ring has exactly 15 ring carbons

325
514/33

Oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings

185
514/34

Oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.)

411
514/32

Oxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bonding

82
514/54

Polysaccharide

2463
514/57

Cellulose or derivative

413
514/55

Chitin or derivative

370
514/59

Dextran or derivative

306
514/58

Dextrin or derivative

623
514/56

Heparin or derivative

563
514/60

Starch or derivative

310
514/61

Tri- or tetrasaccharide

299
514/24

S-glycoside

249
514/169

Cyclopentanohydrophenanthrene ring system doai

611
514/172

Hetero ring containing

287
514/175

-c(=o)-o-is part of a hetero ring (e.g., lactone, etc.)

120
514/174

-o-c-o- is part of a hetero ring (e.g., acetonide, etc.)

195
514/176

Nitrogen containing hetero ring

292
514/173

Spiro ring system

121
514/177

Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system

590
514/178

Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system

782
514/181

21-position substituted

168
514/179

Modified c-ring (except methyl in 13-position) (e.g., double bond containing, substituted, etc.)

708
514/180

9-position substituted

327
514/182

Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system

1129
514/170

Plural compounds containing cyclopentanohydrophenanthrene ring systems

441
514/171

With additional active ingredient

807
514/506

Ester doai

329
514/509

(o=)n(=o)-o-c containing (e.g., nitrate ester, etc.)

118
514/513

C-c(=x)-x-c containing (x is chalcogen and at least one x is other than oxygen)

286
514/514

Carbon bonded to -ncx or -xcn (e.g., cyanate, thiocyanate or isothiocyanate, etc.) (x is chalcogen)

141
514/516

Containing plural -ncx or -xcn groups or a cyano

45
514/515

With an additional active ingredient

60
514/519

Cyano or isocyano bonded directly to carbon

138
514/526

Acyclic

74
514/527

C=o other than as ketone or aldehyde

42
514/528

C(=o)n containing

88
514/520

Benzene ring containing

309
514/523

Additional nitrogen other than cyano

211
514/524

The cyano is bonded directly to a benzene ring

226
514/521

C=o other than as ketone or aldehyde

568
514/522

The cyano is bonded directly to a benzene ring

423
514/525

Two or more of the cyano groups

111
514/510

Polycyclo ring system

491
514/511

Two of the cyclos share at least three ring members (i.e., bridged)

75
514/507

R-c(=x)-n-x-c containing (e.g., hydroxamic acid ester, etc.) (r is c or h and x is chalcogen)

84
514/517

S-x-c containing (e.g., sulfates, etc.) (x is chalcogen)

254
514/518

S of s-x-c attached directly to a benzene ring

109
514/512

X-c(=x)-x containing (e.g., carbonic acid ester, thiocarbonic acid ester, etc.) (x is chalcogen)

185
514/508

X-c=n containing (e.g., imidoester, etc.) (x is chalcogen)

81
514/529

Z-c(=o)-o-y wherein z is hydrogen or an organic radical bonded to the c(=o) by a carbon and y is an organic radical bonded to the oxygen by a carbon

441
514/530

Z contains a cyclopentyl or cyclopentene ring

695
514/531

Z contains a cyclopropyl or cyclopropene ring

586
514/532

Z-c(=o)-o-y, wherein z contains a benzene ring

567
514/544

C(=o)o attached directly through the carbon to a benzene ring

329
514/533

Compound contains two or more c(=o)o groups indirectly bonded together by only conalent bonds

579
514/545

Ketone in z radical

107
514/543

Z forms a phenoxy alkyl or phenoxy alkenyl radical

197
514/534

Z or y radical contains a nitrogen atom

430
514/538

Nitrogen bonded to carbon in z moiety

570
514/541

Aldehyde or ketone in z or y radical

94
514/540

Nitrogen in y moiety

110
514/539

Plural separated benzene rings in z moiety

529
514/542

Z radical contains two or more nitrogen atoms at least one of which forms a c(=x)n group (x is chalcogen)

166
514/535

The nitrogen of the z radical is directly bonded to a benzene ring which is directly bonded to the c(=o) group

413
514/537

With an additional active ingredient

88
514/536

With an agent to enhance topical absorption or with a stabilizing agent

52
514/546

Zc(=o)oy, wherein z is an acyclic radical bonded to the c=o by a carbon and y is an organic radical bonded to the oxygen by a carbon

785
514/547

Compound contains two or more c(=o)o groups

678
514/548

Ring is alcohol moiety

318
514/552

Z contains an unbroken chain of at least seven carbon atoms bonded directly to the c(=o) group

416
514/549

Z radical contains carbon to carbon unsaturation

530
514/551

Z radical contains nitrogen

227
514/550

Z radical contains sulfur or halogen

170
514/715

Ether doai

140
514/722

Acyclic

113
514/723

Plural oxygens

215
514/717

Benzene ring containing

246
514/718

Plural oxygens

208
514/720

Acyclic carbon to carbon unsaturation

138
514/719

Alicyclic ring

86
514/721

Plural benzene rings

224
514/716

Nitrogen containing

115
514/743

Halogenated hydrocarbon doai

80
514/760

Bromine and chlorine as only halogens

8
514/761

Bromine and fluorine as only halogens

19
514/747

Carbocyclic

52
514/751

Benzene ring containing

37
514/752

Alkyne

12
514/754

Plural benzene rings

32
514/753

Polycyclo ring system

18
514/755

Polycyclo ring system

34
514/756

Bicyclo

35
514/748

Two benzene rings directly attached to an acyclic hydrocarbon or acyclic halogenated hydrocarbon (e.g., d.d.t., etc.)

26
514/749

Fluorine containing

27
514/750

With organic ether or -oh containing compound non-doai

5
514/758

Chlorine as only halogen

27
514/759

Fluorine as only halogen

81
514/757

Two or more halogenated hydrocarbons

39
514/744

Unsaturated aliphatic compound

43
514/745

Alkyne

14
514/746

Plural halogenated hydrocarbon compounds

40
514/492

Heavy metal containing doai

681
514/503

Antimony or bismuth

72
514/504

Arsenic

45
514/505

Cadmium or chromium

106
514/499

Copper

275
514/500

With an additional active ingredient

152
514/495

Gold or silver

145
514/502

Iron

284
514/498

Lead

22
514/496

Mercury

41
514/497

Nitrogen containing

22
514/501

Nickel or cobalt

123
514/493

Tin

174
514/494

Zinc

391
514/183

Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai

2142
514/192

1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)

290
514/195

3-position substituent contains -cooc- group

167
514/194

6,6-di-substituted

57
514/197

6-position substituent contains carbocyclic ring

115
514/198

Ampicillin per se or salt thereof

82
514/199

Penicillin g per se or salt thereof (e.g., procaine pencillin g, etc.)

96
514/196

6-position substituent contains hetero ring

131
514/193

Spiro or additional polycyclo ring system

80
514/200

1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)

196
514/201

7,7-di-substituted

166
514/202

Additional hetero ring

363
514/203

3-position substituent contains pyridine ring

191
514/204

3-position substituent contains sulfur

158
514/206

7-position substituent contains hetero ring

390
514/205

The additional hetero ring is part of a polycyclo ring system

75
514/207

Alkyl, hydroxyalkyl, alkoxyalkyl or alkanoyloxyakyl bonded directly to 3-position

144
514/209

Alkyl, hydroxyalkyl, alkoxyalkyl, or alkanoyloxyakyl bonded directly to 3-position

73
514/208

Sulfur containing substituent

62
514/191

Aluminum (including salts)

56
514/359

Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.)

802
514/383

1,2,4-triazoles (including hydrogenated)

1710
514/384

Chalcogen bonded directly to the triazole ring

389
514/403

1,2-diazoles

650
514/404

Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent

348
514/405

Polycyclo ring system having the diazole ring as one of the cyclos

190
514/406

Pyrazoles

1402
514/407

Chalcogen or nitrogen bonded directly to the pyrazole ring by nonionic bonding

705
514/378

1,2-oxazoles (including hydrogenated)

953
514/380

Chalcogen or nitrogen bonded directly to ring carbon of the oxazole ring

378
514/379

Polycyclo ring system having the oxazole ring as one of the cyclos

262
514/372

1,2-thiazoles (including hydrogenated)

801
514/373

Polycyclo ring system having the thiazole ring as one of the cyclos

393
514/385

1,3-diazoles

474
514/401

2-imidazolines

293
514/402

Additional hetero ring

157
514/386

Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent

213
514/392

Divalent chalcogen or acyclic nitrogen double bonded at 2-position, or tautomeric equivalent

377
514/389

Divalent chalcogen or acyclic nitrogen double bonded directly at both 2- and 4- positions, or tautomeric equivalent (e.g., hydantoin, etc.)

312
514/391

Benzene ring bonded directly to the diazole ring by nonionic bonding

136
514/390

Chalcogen or nitrogen bonded directly at 1-, 3-, or 5-position by nonionic bonding

129
514/387

Polycyclo ring system having the diazole ring as one of the cyclos

313
514/388

Nitrogen double bonded directly at 2-position of the diazole ring, or tautomeric equivalent

193
514/396

Imidazoles

800
514/397

Additional hetero ring

1610
514/398

Chalcogen or nitrogen bonded directly to the imidazole ring by nonionic bonding

704
514/399

Chalcogen or nitrogen bonded indirectly to the imidazole ring by nonionic bonding

1031
514/400

At imidazole ring carbon

880
514/393

Polycyclo ring system having the diazole ring as one of the cyclos

362
514/394

Benzo fused at 4,5-positions of the diazole ring

914
514/395

Chalcogen or nitrogen bonded directly at 1-, 2- or 3-position of the diazole ring by nonionic bonding

413
514/374

1,3-oxazoles (including hydrogenated)

1278
514/376

Chalcogen bonded directly to ring carbon of the oxazole ring

668
514/377

Nitrogen bonded directly to ring carbon of the oxazole ring

271
514/375

Polycyclo ring system having the oxazole ring as one of the cyclos

682
514/365

1,3-thiazoles (including hydrogenated)

2153
514/369

Chalcogen bonded directly to ring carbon of the thiazole ring

926
514/370

Nitrogen bonded directly to ring carbon of the thiazole ring

665
514/371

C=x bonded directly to the nitrogen which is bonded directly to the thiazole ring (x is chalcogen)

303
514/366

Polycyclo ring system having the thiazole ring as one of the cyclos

221
514/367

Bicyclo ring system having the thiazole ring as one of the cyclos

918
514/368

Ring nitrogen is shared by the cyclos of the bicyclo ring system (e.g., tetramisole, etc.)

156
514/360

Plural ring chalcogens in the hetero ring

174
514/361

Plural ring nitrogens and a single chalcogen in the hetero ring

474
514/362

1,2,5-thiadiazoles (including hydrogenated)

365
514/363

1,3,4-thiadiazoles (including hydrogenated)

557
514/364

Oxadiazoles (including hydrogenated)

892
514/381

Tetrazoles (including hydrogenated)

1115
514/382

Additional chalcogen containing hetero ring

360
514/408

The five-membered hetero ring consists of one nitrogen and four carbons

708
514/422

Additional hetero ring

1902
514/423

C=x bonded directly to the five-membered hetero ring by nonionic bonding (x is chalcogen)

1531
514/429

Carbocyclic ring bonded directly to the five-membered hetero ring

249
514/424

Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding

763
514/425

Plural chalcogens bonded directly to the five-membered hetero ring by nonionic bonding

325
514/428

Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding

892
514/426

Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding

284
514/410

Polycyclo ring system having the five-membered hetero ring as one of the cyclos

682
514/412

Bicyclo ring system having the five-membered hetero ring as one of the cyclos

487
514/414

Additional hetero ring which is not part of the bicyclo ring system

1125
514/421

Chalcogen bonded directly to ring carbon of the five-membered hetero ring (e.g., adrenochrome, etc.)

189
514/413

Ring nitrogen is shared by the cyclos of the bicyclo ring system

229
514/415

The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.)

1337
514/419

C=x bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (x is chalcogen)

963
514/420

Indomethacine per se or ester thereof

205
514/418

Chalcogen bonded directly to ring carbon of the five-membered hetero ring

476
514/416

The ring nitrogen is bonded directly to nonshared ring carbons of the five-membered hetero ring (e.g., isoindole, etc.)

322
514/417

Plural chalcogens bonded directly to ring carbons of the five-membered hetero ring (e.g., phthalimide, etc.)

252
514/411

Tricyclo ring system having the five-membered hetero ring as one of the cyclos

885
514/409

Spiro ring system

365
514/427

Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.)

523
514/184

Heavy metal containing (including salts)

612
514/188

Hetero ring is six-membered consisting of one nitrogen and five carbons

276
514/190

Mercury

19
514/185

Polycyclo ring system

444
514/186

Bicyclo ring system

155
514/187

Quinolines or isoquinolines (including hydrogenated)

91
514/189

Tin

70
514/211.01

Hetero ring contains seven members including nitrogen, carbon and chalcogen

191
514/211.15

Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding

326
514/211.03

Chalcogen double bonded directly to a ring carbon which is adjacent to the ring nitrogen

83
514/211.04

Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos

62
514/211.05

Bicyclo ring system having the seven-membered hetero ring as one of the cyclos

88
514/211.06

Ring chalcogen and ring nitrogen are in the 1,5-positions of the seven-membered hetero ring

50
514/211.07

Nitrogen attached directly or indirectly to the ring nitrogen of the seven-membered hetero ring by acyclic nonionic bonding (e.g., diltiazem, etc.)

117
514/211.02

Monocyclic cyclopentyl ring bonded directly to the seven-membered hetero ring (e.g., prostaglandins, etc.)

24
514/211.08

Plural ring nitrogens in the seven-membered hetero ring

198
514/211.09

Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos

155
514/211.1

Three ring hetero atoms in the polycyclo ring system

123
514/211.11

Tricyclo ring system having the seven-mmbered hetero ring as one of the cyclos

75
514/211.14

Having -c(=x)-, wherein x is chalcogen, bonded directly to the seven-membered hetero ring

34
514/211.13

Nitrogen bonded directly to ring carbon of the seven-membered hetero ring

68
514/211.12

Ring nitrogen is shared by plural cyclos of the tricyclo ring system

50
514/210.01

Hetero ring is four-membered and includes at least one ring nitrogen

213
514/210.19

Additional hetero ring attached directly or indirectly to the four-membered hetero ring by nonionic bonding

94
514/210.2

The additional hetero ring contains ring nitrogen

208
514/210.21

Polycyclo ring system having the additional hetero ring as one of the cyclos

340
514/210.02

Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen

191
514/210.15

Chalcogen bonded directly to the ring nitrogen of the four-membered ring

46
514/210.03

Polycyclo ring system having the four-membered hetero ring as one of the cyclos

37
514/210.04

Bicyclo ring system having the four-membered hetero ring as one of the cyclos

32
514/210.05

Plural ring hetero atoms in the bicyclo ring system

40
514/210.06

Ring oxygen in the bicyclo ring system

50
514/210.07

The other cyclo of the bicyclo ring system is six-membered

10
514/210.08

1-oxa-5-aza-bicyclo (4.2.0) octanes (including unsaturated)

52
514/210.09

The other cyclo of the bicyclo ring system is five-membered

112
514/210.14

Polycyclo ring system bonded directly to the five-membered cyclo of the bicyclo ring system

22
514/210.1

Sulfur bonded directly to the five-membered cyclo of the bicyclo ring system (e.g., thienamycin, etc.)

77
514/210.11

Additional hetero ring attached directly to the sulfur

22
514/210.12

The additional hetero ring contains ring nitrogen

57
514/210.13

Having -c(=x)-, wherein x is chalcogen, bonded directly to the additional hetero ring

45
514/210.17

Having -c(=x)-, wherein x is chalcogen, bonded directly to the four-membered hetero ring

143
514/210.18

Additional hetero ring attached directly or indirectly to the four-membered hetero ring by nonionic bonding

249
514/210.16

Polycyclo ring system having the four-membered hetero ring as one of the cyclos

89
514/212.01

Hetero ring is seven-membered consisting of one nitrogen and six carbons

254
514/217.03

Additional hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding

349
514/217.08

The additional hetero ring is five-membered and contains nitrogen

245
514/217.09

Plural ring hetero atoms in the additional hetero ring

196
514/217.1

Chalcogen is one of the ring hetero atoms

111
514/217.04

The additional hetero ring is six-membered and contains nitrogen

308
514/217.05

Plural ring hetero atoms in the additional hetero ring

312
514/217.06

The additional hetero ring is a 1,3 diazine (including hydrogenated)

286
514/217.07

Polycyclo ring system having the additional six-membered hetero ring as one of the cyclos

259
514/212.03

Chalcogen double bonded directly to a ring carbon of the seven-membered hetero ring which is adjacent to the ring nitrogen

125
514/212.08

Additional hetero ring attached directly or indirectly by nonionic bonding to the seven-membered hetero ring

191
514/212.04

Polycyclo ring system having the seven-membered hetero ring as one of the cyclos

52
514/212.07

Bicyclo ring system having the seven-membered hetero ring as one of the cyclos

207
514/212.05

Plural cyclos of the polycyclo ring system share ring nitrogen of the seven-membered hetero ring

78
514/212.06

Plural ring hetero atoms in the polycyclo ring system

84
514/217.12

Nitrogen or c(=x), wherein x is chalcogen, attached indirectly to the seven-membered hetero ring by acyclic nonionic bonding

123
514/217.11

Nitrogen or c(=x), wherein x is chalcogen, bonded directly to the seven-membered hetero ring

164
514/213.01

Polycyclo ring system having the seven-membered hetero ring as one of the cyclos

181
514/217.01

3-benzazepines (including hydrogenated)

125
514/217.02

Benzene ring bonded directly to ring carbon of the seven-membered hetero ring

37
514/215

Additional hetero atom in the polycyclo ring system

395
514/214.01

Ring nitrogen of the seven-membered hetero ring is shared by an additional cyclo of the polycyclo ring system

125
514/214.02

Plural ring nitrogens in the polycyclo ring system

150
514/214.03

Two of the cyclos share at least three ring members (i.e., bridged)

142
514/217

Tricyclo ring system having the seven-membered hetero ring a one of the cyclos

345
514/216

Two of the cyclos share at least three ring carbons (i.e., bridged)

93
514/212.02

Spiro

139
514/218

Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms

1072
514/219

Polycyclo ring system having the seven-membered hetero ring as one of the cyclos

213
514/221

Bicyclo ring system having the seven-membered hetero ring as one of the cyclos

685
514/220

Tricyclo ring system having the seven-membered hetero ring as one of the cyclos

734
514/228.8

Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.)

313
514/230.8

Chalcogen bonded directly to ring carbon of 1,4-oxazine ring

170
514/231.2

Morpholines (i.e., fully hydrogenated 1,4- oxazines)

446
514/231.5

Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding

623
514/231.8

Plural morpholine rings attached directly or indirectly to each other by nonionic bonding

133
514/232.2

Additional hetero ring attached directly or indirectly to the morpholines by nonionic bonding

216
514/232.5

Polycyclo ring system having the additional hetero ring as one of the cyclos

272
514/232.8

Polycyclo ring system having the additional hetero ring as one of the cyclos

612
514/233.5

Bicyclo ring system having the additional hetero ring as one of the cyclos

408
514/233.8

Plural ring hetero atoms in the bicyclo ring system

445
514/234.5

Plural ring nitrogens in the bicyclo ring system

609
514/234.8

Quinoxalines (including hydrogenated)

82
514/234.2

Three or more ring hetero atoms in the bicyclo ring system

536
514/235.2

Ring nitrogen in the bicyclo ring system

665
514/233.2

Ring nitrogen shared by two of the cyclos

448
514/235.5

Ring nitrogen in the additional hetero ring

734
514/235.8

Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)

1029
514/236.5

The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)

290
514/236.2

Three or more ring hetero atoms in the additional hetero ring

385
514/236.8

Ring chalcogen in the additional hetero ring (e.g., oxazole, etc.)

362
514/237.2

The additional hetero ring is attached indirectly to the morpholine ring by an acyclic chain having a hetero atom as a chain member

286
514/239.5

Carbocyclic ring attached indirectly to the morpholine ring by nonionic bonding

232
514/238.8

Chalcogen attached indirectly to the morpholine ring by acyclic nonionic bonding

190
514/239.2

The chalcogen is bonded directly to two carbon atoms

201
514/237.5

Having -c(=x)-, wherein x is chalcogen, bonded directly to the morpholine ring

367
514/237.8

Nitrogen attached indirectly to the morpholine ring by acyclic nonionic bonding

346
514/238.2

Chalcogen attached directly to the nitrogen by nonionic bonding

167
514/238.5

The nitrogen is double or triple bonded directly to carbon

76
514/229.5

Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., maytansinoids, etc.)

172
514/230.5

Bicyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,4-benzoxazines, etc.)

819
514/229.8

Tricyclo ring system having the six-membered hetero ring as one of the cyclos

178
514/230.2

Ring nitrogen shared by two of the cyclos

171
514/229.2

Three or more ring hetero atoms in the six-membered hetero ring

223
514/222.2

Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members

199
514/226.8

1,3-thiazines

178
514/227.2

Chalcogen or nitrogen bonded directly to ring carbon of the six-membered hetero ring

142
514/227.5

1,4-thiazines

391
514/227.8

Additional hetero ring attached directly or indirectly to the 1,4-thiazine by nonionic bonding

678
514/228.2

Polycyclo ring system having the additional hetero ring as one of the cyclos

586
514/228.5

Three or more ring hetero atoms in the polycyclo ring system

276
514/224.2

Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.)

335
514/224.5

At least three cyclos in the polycyclo ring system

193
514/224.8

Phenothiazines (including hydrogenated)

111
514/226.2

Chalcogen or nitrogen attached indirectly to the phenothiazine ring nitrogen by acyclic nonionic bonding

139
514/225.2

Hetero ring attached directly or indirectly to the phenothiazine ring nitrogen by acyclic nonionic bonding

70
514/225.8

The hetero ring contains plural ring nitrogens

72
514/225.5

The hetero ring is monocyclic piperidine

74
514/226.5

One of the cyclos is a 1,2-thiazine (e.g.,1,2-benzothiazines, etc.)

196
514/222.5

Three or more ring hetero atoms in the six-membered hetero ring

219
514/223.8

1,3,5-thiadiazines

47
514/222.8

Polycyclo ring system having the six-membered hetero ring as one of the cyclos

143
514/223.2

1,2,4 - benzothiadiazine - 1,1 - dioxides (including hydrogenated)

133
514/223.5

With additional active ingredient

82
514/277

Hetero ring is six-membered consisting of one nitrogen and five carbon atoms

1056
514/336

Additional hetero ring containing

1014
514/340

Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.)

1234
514/342

Ring sulfur in the additional hetero ring

942
514/343

The additional hetero ring consists of one nitrogen and four carbons (e.g., nicotine, etc.)

914
514/341

The additional hetero ring consists of two nitrogens and three carbons

1179
514/337

The additional hetero ring is one of the cyclos in a polycyclo ring system

651
514/338

Plural hetero atoms in the polycyclo ring system

1255
514/339

Ring nitrogen in the polycyclo ring system

883
514/354

C=o bonded directly to the six-membered hetero ring

519
514/355

At 3-position

415
514/356

C=o in a c(=o)o group (e.g., nicotinic acid, etc.)

757
514/345

Chalcogen bonded directly to ring carbon of the six-membered hetero ring

832
514/350

C=o bonded directly to the six-membered hetero ring

352
514/346

Chalcogen and acyclic nitrogen bonded directly to the same carbon

248
514/347

Chalcogen bonded directly to chalcogen

165
514/348

Chalcogens bonded directly to at least two ring carbons of the six-membered hetero ring

273
514/349

Nitrogen attached directly to the six-membered hetero ring by nonionic bonding

325
514/351

Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding

537
514/344

Cyano bonded directly to the six-membered hetero ring

279
514/352

Nitrogen attached directly to the six-membered hetero ring by nonionic bonding

925
514/353

Plural acyclic nitrogens bonded directly to the same carbon or bonded directly to each other

196
514/357

Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding

1493
514/315

Piperidines

965
514/317

Additional ring containing

1147
514/330

C=x bonded directly to the piperidine ring (x is chalcogen)

662
514/327

Chalcogen bonded directly to ring carbon of the piperidine ring

579
514/328

Plural chalcogens bonded directly to ring carbons of the piperidine ring

146
514/329

Nitrogen attached directly to the piperidine ring by nonionic bonding

371
514/331

Nitrogen attached indirectly to the piperidine ring by nonionic bonding

808
514/326

The additional ring is a hetero ring

2031
514/318

The additional ring is a six-membered hetero ring consisting of one nitrogen and five carbon atoms

1545
514/319

The additional ring is one of the cyclos in a polycyclo ring system

659
514/320

Hetero ring in the polycyclo ring system

743
514/321

Plural hetero atoms in the polycyclo ring system

905
514/322

Plural ring nitrogens in the polycyclo ring system

791
514/323

Ring nitrogen in the polycyclo ring system

1011
514/324

Ring sulfur in the polycyclo ring system

538
514/325

Polycyclo ring system is tricyclo-carbocyclic

193
514/316

Plural piperidine rings

753
514/332

Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms

633
514/333

Additional hetero ring other than the six-membered hetero rings

815
514/335

Chalcogen bonded directly to a ring carbon of the six-membered hetero ring

268
514/334

The six-membered hetero rings are bonded directly to each other

236
514/279

Polycyclo ring system having the six-membered hetero ring as one of the cyclos

402
514/299

Bicyclo ring system having the six-membered hetero ring as one of the cyclos

772
514/307

Isoquinolines (including hydrogenated)

1364
514/309

Chalcogen attached directly to the six-membered hetero ring by nonionic bonding

553
514/310

Nitrogen, other than as nitro or nitroso, attached directly to the isoquinoline ring system by nonionic bonding

466
514/308

Plural isoquinoline ring systems attached directly or indirectly to each other by nonionic bonding

118
514/300

Plural hetero atoms in the bicyclo ring system

1537
514/303

Exactly three ring nitrogens in the bicyclo ring system

892
514/302

Ring oxygen in the bicyclo ring system

417
514/301

Ring sulfur in the bicyclo ring system

547
514/311

Quinolines (including hydrogenated)

1258
514/314

Additional hetero ring attached directly or indirectly to the quinoline ring system by nonionic bonding

1511
514/312

Chalcogen attached directly to the six-membered hetero ring by nonionic bonding

1659
514/313

Nitrogen, other than as nitro or nitroso, attached directly to the six membered hetero ring by nonionic bonding

689
514/306

Quinolizines (including hydrogenated)

160
514/305

Quinuclidines (including unsaturation)

497
514/304

Tropanes (including nor or dehydro form)

452
514/280

Pentacyclo ring system having the six-membered hetero ring as one of the cyclos

249
514/283

Ring nitrogen in the pentacyclo ring system is shared by five-membered cyclo and six-membered cyclo (e.g., vincamine, etc.)

443
514/281

Two of the cyclos share at least three ring members (i.e., bridged)

80
514/282

One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.)

581
514/284

Tetracyclo ring system having the six-membered hetero ring as one of the cyclos

371
514/285

Plural hetero atoms in the tetracyclo ring system (e.g., acronycines, etc.)

221
514/288

Ring carbon is shared by three of the cyclos

246
514/287

Three or more hetero atoms in the tetracyclo ring system

171
514/286

Two of the cyclos share at least three ring members (i.e., bridged)

73
514/289

Two of the cyclos share at least three ring members (i.e., bridged) (e.g., morphinans, etc.)

217
514/290

Tricyclo ring system having the six-membered hetero ring as one of the cyclos

502
514/297

Acridines (including hydrogenated)

238
514/298

Phenanthridines (including hydrogenated)

80
514/291

Plural hetero atoms in the tricyclo ring system

827
514/292

Plural ring nitrogens in the tricyclo ring system

617
514/293

Three or more hetero atoms in the tricyclo ring system

471
514/296

Ring carbons shared by each of the three cyclos (e.g., 1,8-naphthalimides, etc.)

97
514/294

Ring nitrogen is shared by two of the cyclos

255
514/295

Two of the cyclos share at least three ring carbons (i.e., bridged) (e.g., benzomorphans, etc.)

102
514/278

Spiro ring system

1043
514/358

The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)

163
514/241

Hetero ring is six-membered consisting of three nitrogens and three carbon atoms

649
514/242

Asymmetrical (e.g., 1,2,4-triazine, etc.)

483
514/243

Polycyclo ring system having the hetero ring as one of the cyclos

345
514/244

Hexamethylenetetramines

48
514/245

Nitrogen bonded directly to ring carbon of the hetero ring

390
514/246

Polycyclo ring system having a 1,3,5-triazine as one of the cyclos

121
514/247

Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.)

897
514/252.01

1,2 diazine attached directly or indirectly to an additional hetero ring by nonionic bonding

369
514/252.02

The additional hetero ring is a diazine

500
514/252.05

The additional hetero ring is a five-membered nitrogen hetero ring

351
514/252.06

Polycyclo ring system having the additional five-membered hetero ring as one of the cyclos

218
514/252.03

The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms

424
514/252.04

Polycyclo ring system having the additional six-membered hetero ring as one of the cyclos

262
514/256

1,3-diazines (e.g., pyrimidines, etc.)

2566
514/275

Nitrogen bonded directly to the 1,3-diazine at 2-position by a single bond

1460
514/257

Polycyclo ring system having 1,3-diazine as one of the cyclos

265
514/258.1

Bicyclo ring system having the 1,3-diazine as one of the cyclos

219
514/259.1

A ring nitrogen is shared by the two cyclos of the bicyclo ring system (e.g., pyrrolo [1,2-a]pyrimidine, imidazo[1,2-a]pyrimidine, etc.)

141
514/259.5

Chalcogen bonded directly to a ring carbon of the 1,3-diazine ring

71
514/259.2

Ring chalcogen in the bicyclo ring system

83
514/259.4

The second ring of the bicyclo ring system is six-membered, consisting of five ring carbons and the shared ring nitrogen (e.g., pyrido[1,2-a]pyrimidine, etc.)

51
514/259.41

Additional hetero ring is attached directly or indirectly to the bicyclo ring system by nonionic bonding

124
514/259.3

The shared ring nitrogen is bonded directly to a ring nitrogen of the second ring of the bicyclo ring system (e.g., pyrazolo[1,5-a]pyrimidine, etc.)

166
514/259.31

The second ring of the bicyclo ring system is a five-membered hetero ring including three ring nitrogens (e.g., triazolo[1,5-a]pyrimidine, etc.)

116
514/261.1

Exactly five ring nitrogens in the bicyclo ring system (e.g., triazolo[4,5-d]pyrimidine, etc.)

116
514/262.1

Exactly four ring nitrogens in the bicyclo ring system

463
514/263.1

Purine (including hydrogenated)

115
514/263.2

Additional hetero ring attached directly or indirectly to the purine ring system by nonionic bonding

289
514/263.23

The additional hetero ring consists of carbon and chalcogen as the only ring members

159
514/263.24

The additional chalcogen containing hetero ring is part of a polycyclo ring system

65
514/263.21

The additional hetero ring is a 1,3-diazine ring (including hydrogenated)

115
514/263.22

The additional hetero ring is six-membered consisting of one nitrogen and five carbons

276
514/263.3

Chalcogen bonded directly to a ring carbon of the purine ring system

125
514/263.33

Chalcogen bonded directly to the 2-,6-, and 8-positions of the purine ring system

16
514/263.34

Chalcogen bonded directly to the 2-and 6- positions of the purine ring system (e.g., theophylline, etc.)

244
514/263.36

Chalcogen attached indirectly to the purine ring system by acyclic nonionic bonding

141
514/263.35

Nitrogen attached indirectly to the purine ring system by acyclic nonionic bonding

72
514/263.37

Nitrogen bonded directly to a ring carbon of the purine ring system (e.g., guanine, etc.)

111
514/263.38

Chalcogen attached indirectly to the 9- position of the purine ring system by acyclic nonionic bonding

128
514/263.31

With perservative, stabilizer, or an additional active ingredient

160
514/263.32

Nitrogen containing hetero ring in the perservative, stabilizer, or additional active ingredient

100
514/263.4

Nitrogen bonded directly to ring carbon of the purine ring system (e.g., adenine, etc.)

253
514/266.1

Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle)

196
514/266.2

Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding

416
514/266.24

The additional hetero ring consists of carbon and chalcogen as the only ring members

151
514/266.23

The additional hetero ring is five-membered consisting of carbon and plural nitrogens as the only ring members

200
514/266.21

The additional hetero ring is six-membered consisting of one nitrogen and five carbons

276
514/266.22

Piperidinyl or tetrahydropyridyl

283
514/266.3

Chalcogen bonded directly to a ring carbon of the 1,3-diazine ring of the quinazoline ring system

300
514/266.31

Carbocyclic ring bonded directly to a ring carbon of the quinazoline ring system

101
514/266.4

Nitrogen bonded directly to ring carbon of the 1,3-diazine ring of the quinazoline ring system

283
514/260.1

Ring chalcogen in the bicyclo ring system

315
514/264.1

The other cyclo in the bicyclo ring system is a pyridine ring (including hydrogenated) (e.g., pyrido[2,3-d]pyrimidine, etc.)

243
514/264.11

Nitrogen bonded directly to ring carbon of the 1,3-diazine ring of the bicyclo ring system

161
514/265.1

The other cyclo in the bicyclo ring system is a pyrrole ring (including hydrogenated) (e.g., pyrrolo[3,2-d]pyrimidine, etc.)

346
514/267

Tricyclo ring system having 1,3-diazine as one of the cyclos

668
514/268

Perimidine (including hydrogenated)

24
514/269

Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety

1422
514/270

Barbituric acid or derivative (including thioanalogs)

150
514/271

Two or more barbituric acid compounds or with an additional active ingredient or stabilizer

26
514/274

Chalcogen bonded directly to pyrimidine at 2-position

1223
514/272

Nitrogen bonded directly to the 1,3-diazine at 2-position

584
514/273

The nitrogen is part of a hetero ring

117
514/276

Thiamines (e.g., vitamin b1, etc.)

148
514/252.1

1,4 diazines

405
514/255.05

Additional hetero ring attached directly or indirectly to the 1,4-diazine ring by nonionic bonding

1306
514/255.06

Nitrogen or -c(=x)-, wherein x is chalcogen, bonded directly to ring carbon of the 1,4-diazine ring

351
514/252.12

Piperazines (i.e., fully hydrogenated 1,4-diazines)

704
514/252.13

Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding

639
514/254.1

Ring oxygen in the additional hetero ring

218
514/254.11

Polycyclo ring system having the additional oxygen hetero ring as one of the cyclos

507
514/252.14

The additional hetero ring is a 1,3 diazine ring

486
514/252.18

Additional six-membered hetero ring consisting of five ring carbons and one ring nitrogen attached directly or indirectly to the 1,3-diazine by nonionic bonding

329
514/252.19

Five-membered nitrogen hetero ring attached directly or indirectly to the 1,3-diazine ring by nonionic bonding

312
514/252.2

Oxygen hetero ring attached directly or indirectly to the 1,3-diazine ring by nonionic bonding

104
514/252.16

Polycyclo ring system having the additional 1,3-diazine ring as one of the cyclos

443
514/252.17

The polycyclo ring system is quinazoline (including hydrogenated)

263
514/252.15

Spiro ring system containing

65
514/254.01

The additional hetero ring is five-membered having ring nitrogen

391
514/254.05

Plural nitrogens in the additional five-membered hetero ring

513
514/254.07

Chalcogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding

221
514/254.06

Polycyclo ring system having the plural nitrogen containing additional five-membered hetero ring as one of the cyclos

325
514/254.08

Polycyclo ring system having the additional five-membered nitrogen hetero ring as one of the cyclos

172
514/254.09

Indole ring system (including hydrogenated) attached directly or indirectly to the piperazine ring by nonionic bonding

420
514/254.02

The additional five-membered hetero ring also has chalcogen as a ring member

557
514/254.04

The additional five-membered hetero ring consists of three ring carbons, and of nitrogen and chalcogen in adjacent ring positions (e.g., isoxazolyl, isothiazolyl, etc.)

273
514/254.03

The additional five-membered hetero ring consists of two ring carbons, two ring nitrogens, and one ring chalcogen (e.g., oxadiazolyl, thiadiazolyl, etc.)

186
514/253.01

The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms

692
514/253.12

Chalcogen bonded directly to ring carbon of the additional six-membered nitrogen containing hetero ring

185
514/253.11

Chalcogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding

256
514/253.09

Five-membered nitrogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding

518
514/253.1

The five-membered nitrogen hetero ring has chalcogen as a ring member

237
514/253.13

Having -c(=x)-, wherein x is chalcogen, bonded directly to the additional six-membered nitrogen hetero ring

259
514/253.02

Polycyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos

107
514/253.04

Bicyclo ring having the additional six-membered nitrogen hetero ring as one of the cyclos

461
514/253.05

Isoquinolines (including hydrogenated)

211
514/253.06

Quinolines (including hydrogenated)

340
514/253.07

Chalcogen bonded directly to carbon of the hetero ring of the quinoline ring system

178
514/253.08

Having -c(=x)-, wherein x is chalcogen, bonded directly to carbon of the hetero ring of the quinoline ring system

185
514/253.03

Tricyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos

274
514/255.03

Carbocyclic ring bonded directly to the piperazine ring

470
514/255.02

Chalcogen bonded directly to a piperazine ring carbon

158
514/255.01

Nitrogen or -c(=x)-, wherein x is chalcogen, bonded directly to the piperazine ring

557
514/255.04

Plural carbocyclic rings bonded directly to the same acyclic carbon atom which is attached directly or indirectly to the piperazine ring by nonionic bonding

207
514/252.11

Plural 1,4-diazine rings attached directly or indirectly to each other by nonionic bonding

607
514/248

Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos

1107
514/249

1,4-diazine as one of the cyclos

1713
514/250

At least three rings in the polycyclo ring system

831
514/251

Isoalloxazine (e.g., riboflavins, vitamin b2, etc.)

235
514/449

Oxygen containing hetero ring

745
514/450

The hetero ring has at least seven members

836
514/461

The hetero ring is five-membered

798
514/473

Chalcogen bonded directly to the hetero ring

509
514/474

Ascorbic acid or derivative (e.g., vitamin c, etc.)

692
514/471

Nitrogen containing

867
514/472

The nitrogen bonded directly to the hetero ring

213
514/463

Plural ring oxygens in the hetero ring

192
514/464

Bicyclo ring system having the hetero ring as one of the cyclos (e.g., methylenedioxyphenyl group, etc.)

385
514/466

Nitrogen containing

287
514/465

The hetero ring is substituted

265
514/467

Only two ring oxygens in the hetero ring which is not a polycyclo ring system (e.g., dioxolane, etc.)

236
514/468

Polycyclo ring system having the hetero ring as one of the cyclos

449
514/469

Bicyclo ring system having the hetero ring as one of the cyclos

884
514/470

Chalcogen or nitrogen bonded directly to the hetero ring

414
514/462

Spiro ring system

244
514/451

The hetero ring is six-membered

384
514/460

Chalcogen bonded directly to ring carbon of the hetero ring

756
514/459

Nitrogen containing

456
514/452

Plural ring oxygens in the hetero ring

627
514/453

Polycyclo ring system having the hetero ring as one of the cyclos

415
514/456

Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.)

1560
514/457

Coumarins (including hydrogenated)

308
514/458

Tocopherols (e.g., vitamin e, etc.)

721
514/454

Tricyclo ring system having the hetero ring as one of the cyclos

384
514/455

Chalcogen bonded directly to ring carbon of the hetero ring

418
514/475

The hetero ring is three-membered

292
514/430

Sulfur containing hetero ring

127
514/431

The hetero ring has at least seven members

230
514/438

The hetero ring is five-membered

958
514/444

Additional hetero ring

658
514/448

C=o bonded directly to the hetero ring (x is chalcogen)

434
514/445

Chalcogen bonded directly to ring carbon of the hetero ring

458
514/446

Chalcogen bonded directly to ring sulfur by nonionic bonding

51
514/447

Nitrogen bonded directly to the hetero ring

252
514/439

Plural hetero atoms in the hetero ring

159
514/440

Only two ring sulfurs in the hetero ring

194
514/441

Chalcogen bonded directly to ring carbon of the hetero ring

76
514/442

Nitrogen bonded directly to the hetero ring by nonionic bonding

41
514/443

Polycyclo ring system having the hetero ring as one of the cyclos

932
514/432

The hetero ring is six-membered

431
514/433

Plural hetero atoms in the hetero ring

73
514/434

Polycyclo ring system having the hetero ring as one of the cyclos

85
514/435

Three or more hetero atoms in the hetero ring

31
514/436

Two ring sulfurs in the hetero ring

91
514/437

Tricyclo ring system having the hetero ring as one of the cyclos

114
 

Heterocyclic carbon cpmpounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai

 
 

Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.)

 
514/762

Hydrocarbon doai

190
514/763

Carbocyclic

151
514/764

Benzene ring containing

107
514/765

Polycyclo ring system

80
514/766

Polycyclo ring system

88
514/767

With phosphorus containing non-doai

8
514/768

With sulfur containing non-doai

14
514/675

Ketone doai

216
514/690

Alicyclic ring containing

260
514/691

Plural alicyclic rings

134
514/692

Camphor or nuclear substituted derivatives thereof

49
514/678

Benzene ring containing

133
514/688

C=o bonded directly to benzene ring (e.g., acetophenone, etc.)

84
514/689

Oxygen single bonded to carbon

77
514/679

Plural rings

117
514/683

Alicyclic ring

55
514/684

Five-membered alicyclic ring

42
514/685

C=o bonded directly to benzene ring

114
514/686

Two benzene rings bonded directly to the same c=o

39
514/687

Oxygen single bonded to carbon

55
514/680

Polycyclo ring system

141
514/681

Bicyclo

140
514/682

Naphthyl ring system

146
514/676

Nitrogen containing

107
514/677

Bicyclo ring system having a benzene ring as one of the cyclos

28
514/22

Lignin or derivative doai

51
514/476

N-c(=x)x containing (x is chalcogen) doai

179
514/478

N-c(=x)-x-c containing

320
514/482

N-c(=x)-n, n-c(=n)n, n-n, nitrogen directly bonded to oxygen by nonionic bonding or cyano containing

116
514/483

Plural n-c(=x)-x groups

136
514/480

Polycyclo ring system attached by nonionic bonding

83
514/481

Naphthyl ring system

129
514/484

Ring in acid moiety

87
514/485

The ring is a benzene ring

142
514/486

Phenoxy in acid moiety

97
514/488

Ring in alcohol moiety

83
514/487

The benzene ring is attached to nitrogen through an acyclic carbon or carbon chain

103
514/489

Ring in alcohol moiety

91
514/490

Ring attached directly to oxygen of n-c(=0)-0

126
514/479

With an additional active ingredient

214
514/477

N-c(=x)-x-n containing

121
514/491

With an additional active ingredient

82
514/740

Nitrogen containing compound doai

149
514/741

Benzene ring containing

168
514/742

Polynitro

67
514/579

Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai

301
514/663

Acyclic

134
514/666

Aldehyde or ketone containing

30
514/667

C-o-group containing

115
514/670

Monoether

34
514/668

Polyether

46
514/669

Polyhydroxy

105
514/671

Carbon to carbon unsaturation

79
514/672

Halogen bonded directly to carbon

51
514/664

N-n containing (e.g., aminimine, hydrazine, etc.)

17
514/673

Plural amino nitrogens

84
514/674

Three or more amino nitrogens

109
514/665

Sulfur containing

160
514/659

Alicyclic ring or ring system and amino nitrogen are attached indirectly by an acyclic carbon or acyclic chain

126
514/631

Amidines (i.e., n=c-n)

126
514/632

Amidino hydrazines or hydrazones (i.e., n-n=c-n or n=c-n-n)

106
514/633

Amidoximes (i.e., n-c=n-o)

61
514/637

Benzene ring containing

138
514/634

Guanidines (i.e., n=c(-n)-n)

373
514/635

Biguanides (i.e., n=c(-n)-n(n-)c=n)

253
514/636

Polyamidines

70
514/644

Amine oxides

60
514/646

Benzene ring containing

661
514/647

Amino nitrogen and a ring bonded directly to the same ring and any other amino nitrogen in the compound is bonded directly to one of the rings

196
514/649

Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain

610
514/651

Ether oxygen is part of the chain

416
514/652

Alkanol group only between the amino nitrogen and an ether oxygen which is bonded directly to the aryl ring or aryl ring system (i.e., aryloxy alkanol amines)

166
514/653

Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)

489
514/655

The aryl ring or aryl ring system and amino nitrogen are bonded directly to the same acylic carbon, which carbon additionally has only hydrogen or acyclic hydrocarbyl substituents bonded directly thereto

231
514/650

The aryl ring or aryl ring system is bonded directly to another ring or ring system

159
514/654

The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only

446
514/656

Polycyclo ring system

121
514/657

Bicyclo ring system

241
514/648

Two aryl rings or aryl ring systems bonded directly to the same acyclic carbon

306
514/658

Two benzene rings bonded directly to the same nitrogen

68
514/613

Carboxamides (i.e., r-c(=o)-n, wherein r is a radical having carbon bonded directly to the c(=o)-n or is hydrogen and wherein any substituent attached to nitrogen will be referred to as e)

495
514/614

N-n containing (e.g., aminimine, hydrazine, etc.)

122
514/615

R contains benzene ring

176
514/623

Plural alicyclic rings in r

76
514/616

Plural carboxamide groups or plural c=o groups bonded directly to the same nitrogen

681
514/617

R contains benzene ring

851
514/622

C-o- group in r

350
514/621

C=o in r

185
514/619

Nitrogen in r

569
514/620

The nitrogen in r is an amino nitrogen attached indirectly to a ring by acyclic bonding

388
514/618

Sulfur in r

390
514/625

R is acyclic

293
514/627

Carbon to carbon unsaturation in r

251
514/628

Halogen bonded directly to carbon in r

116
514/626

Nitrogen in r

320
514/629

R is hydrogen or a lower saturated alkyl of less than seven carbons

430
514/630

A ring or polycyclo ring system in a substituent e is attached indirectly to the carboxamide nitrogen or to an amino nitrogen in substituent e by acyclic nonionic bonding

199
514/624

Three-membered ring in r

94
514/609

Cyanamides (i.e., compounds containing cyano bonded directly to amino nitrogen)

60
514/612

Haloamines (i.e., compounds containing halogen attached directly to amino nitrogen by nonionic bonding)

13
514/607

N-s-n containing or contains a nitrogen bonded directly to a s=o group (e.g., sulfinamides, etc.)

33
514/606

N-s-s containing

9
514/610

Nitramines (i.e., compounds containing nitro bonded directly to amino nitrogen)

26
514/638

Nitrogen double bonded directly to carbon

72
514/641

Aldimines or ketimines which contain a benzene ring (i.e., rc=n wherein r is c or h)

66
514/639

Hydrazones (i.e., c=n-n)

63
514/640

Oximes (i.e., c=n-o-)

236
514/611

Nitrosamines (i.e., compounds containing nitroso bonded directly to amino nitrogen)

51
514/645

Nitroxides, oxyamines or hydroxylamines (i.e., n-o or n-oh)

167
514/660

Plural alicyclic rings

47
514/661

Polycyclo ring system

52
514/662

Tricyclo ring system

55
514/642

Quaternary ammonium containing

482
514/643

Benzene ring containing

320
514/600

Sulfamides (i.e., n-(o=)s(=o)-n)

95
514/601

Sulfonamides (i.e., q-(o=)s(=o)-n, wherein q is a substituent and wherein any substituent attached to the nitrogen will be referred to as e)

265
514/602

Q contains benzene ring

311
514/603

Nitrogen in q

356
514/604

Q is monocyclic

340
514/605

Q is acyclic and benzene ring in a substituent e

300
514/608

Sulfur attached directly to amino nitrogen by nonionic bonding (e.g., sulfenamides, etc.)

73
514/599

Thiocarboxamides, (i.e., c(=s)-n)

161
514/580

Thioureas (i.e., n-c(=s)-n

71
514/585

Benzene ring containing

92
514/586

Nitrogen attached indirectly to the -c(=s)-group by nonionic bonding

89
514/587

Oxygen containing

68
514/584

C=o, sulfur or cyano attached directly to thiourea nitrogen by nonionic bonding

53
514/581

Thiocarbazides or thiosemicarbazides (i.e., n-n-c(=s)-n containing)

18
514/582

Thiocarbazones or thiosemicarbazones (i.e., c=n-n-c(=s)-n containing)

16
514/583

Benzene ring containing

21
514/588

Ureas (i.e., n-c(=o)-n)

294
514/594

Additional c=o bonded directly to urea nitrogen

158
514/595

Benzene ring containing

199
514/596

Benzene ring bonded directly to urea nitrogen

245
514/597

Benzene ring is part of a substituent which contains nitrogen

215
514/598

Benzene ring is part of a substituent which contains oxygen

156
514/591

Biurets (i.e., n-c(=o)-n-c(=o)-n)

16
514/590

Carbazides or semicarbazides (i.e., n-n-c(=o)-n containing)

59
514/589

Nitro or nitroso bonded directly to amino nitrogen (e.g., nitramine, nitrosamine, nitro-urea, etc.)

41
514/592

Sulfur attached directly to urea nitrogen by nonionic bonding

73
514/593

Sulfur is part of a substituent which contains additional nitrogen

55
514/159

Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative doai

380
514/165

Aspirin per se (i.e., 2-(acetyloxy)benozic acid)

229
514/166

Nitrogen containing (e.g., anilides, etc.)

163
514/160

With additional ortho-hydroxybenzoic acid compound

55
514/163

With carboxylic acid, ester or metal salt thereof

103
514/161

With heterocyclic compound

203
514/162

With organic nitrogen containing compound

133
514/164

With organic oxygen containing compound

102
514/155

Para-n-benzene - sulfoxy-n containing doai, and said benzene ring is not part of a polycyclo ring system

77
514/156

Hetero ring containing

50
514/158

The hetero ring is five-membered

88
514/157

The hetero ring is six-membered and includes at least two nitrogens and no other hetero atoms

102
514/2

Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai

7690
514/14

12 to 15 peptide repeating units in known peptide chain

1156
514/13

16 to 24 peptide repeating units in known peptide chain

1207
514/19

2 peptide repeating units in known peptide chain

1352
514/20

Guanidine containing

114
514/12

25 or more peptide repeating units in known peptide chain structure

5904
514/18

3 or 4 peptide repeating units in known peptide chain

1666
514/17

5 or 6 peptide repeating units in known peptide chain

1125
514/16

7 or 8 peptide repeating units in known peptide chain

1087
514/15

9 to 11 peptide repeating units in known peptide chain

1423
514/9

Cyclopeptides

730
514/10

Bicyclic

147
514/11

Monocyclic

1006
514/8

Glycoprotein (carbohydrate containing)

2102
514/6

Heavy metal containing (e.g., hemoglobin, etc.)

461
514/3

Insulin or derivative

639
514/4

With an additional active ingredient

338
514/5

Iodine containing

44
514/7

Phosphorus containing

211
514/21

Produced by or extracted from animal tissue

2400
514/714

Peroxide doai

141
514/75

Phosphorus containing other than solely as part of an inorganic ion in an addition salt doai

320
514/140

(c)(r)p=x(-xc) containing (i.e., phosphinate (x is chalcogen; r is c or h)

40
514/141

(cx-) (c)p=x(xh) or (cx-) (r)p=x(xc) containing (e.g., phosphonate, etc.) (x is chalcogen; r is c or h)

190
514/142

(cx-)(c)p(c),(cx-)(rx-)p(c),(cx-)p(xh)(xh) or (cx-)(cx-)p(-xr) containing (x is chalcogen; r is c or h) (e.g., phosphinite, phosphite, etc.)

31
514/134

Acyclic carbon to carbon unsaturation

80
514/135

Alkyne

22
514/136

Phosphate ester having three ester groups (e.g., ddvp, etc.)

67
514/76

Amine addition salt of organic phosphorus containing acid

137
514/120

C=o other than as ketone or aldehyde, attached directly or indirectly to phosphorus

242
514/124

C=o, other than as ketone or aldehyde, attached to a benzene ring

48
514/121

Plural c=o groups, other than as ketone or aldehyde

86
514/122

Malathion

61
514/123

With n-c(=o)-o containing compound

6
514/112

Cyano or isocyano containing

84
514/113

Cyano or isocyano bonded directly to a benzene ring

64
514/143

Ester of (hx)p=x(xh)(xh) (x is chalcogen) (e.g., phosphate, etc.)

119
514/148

Diester

54
514/144

Triester

88
514/147

One benzene ring bonded directly to chalcogen

76
514/145

Three benzene rings bonded directly to chalcogen

19
514/146

Two benzene rings bonded directly to chalcogen

28
514/77

Inner salt (e.g., betaine, etc.)

191
514/78

Lecithins

406
514/125

Ketone or aldehyde containing

60
514/131

Nitro group bonded to a carbon

42
514/132

Nitro group is directly bonded to a benzene ring which benzene ring is either bonded directly bonded to phosphorus or indirectly bonded to phosphorus through a chalcogen

68
514/133

Two or more such benzene rings

6
514/137

Nitrogen bonded directly to phosphorus

68
514/138

N-p-n or n-n-p containing

16
514/79

Nitrogen containing hetero ring

204
514/91

Hetero ring is five-membered

205
514/92

Two or more hetero atoms in the five-membered ring

193
514/94

Diazoles (including hydrogenated)

184
514/93

Triazoles (including hydrogenated)

77
514/89

Hetero ring is six-membered and includes only one ring nitrogen

526
514/90

Chalcogen in the six-membered hetero ring

132
514/84

Hetero ring is six-membered consisting of three nitrogens and three carbons

39
514/85

Hetero ring is six-membered consisting of two nitrogens and four carbons

192
514/86

Nitrogen atoms occupy 1 and 3- positions

239
514/87

Px- bonded directly to 1,3-diazine at 2- position (x is chalcogen)

29
514/88

Two or more px- groups attached to the same 1,3-diazine (x is chalcogen)

23
514/83

Hetero ring is three-membered consisting of one nitrogen and two carbons

23
514/80

Polycylo ring system having a ring nitrogen in the system

485
514/81

Nonshared hetero atoms in at least two rings of the polycyclo ring system

426
514/82

Quinolinyl or isoquinolinyl (including hydrogenated)

113
514/114

Nitrogen, other than nitro or nitroso, bonded indirectly to phosphorus

435
514/119

C(=o)n containing

214
514/115

N-c(=x)-n containing (x is chalcogen)

36
514/118

Phosphorus single bonded directly to nitrogen

66
514/116

Sulfur single bonded directly to nitrogen

22
514/117

N-(o=)s(=o) containing (i.e., sulfonamides)

49
514/129

Oxygen bonded directly to a carbon or hydrogen and wherein the oxygen is not bonded directly to phosphorus

168
514/130

The oxygen is bonded directly to a benzene ring

75
514/99

Oxygen containing hetero ring

151
514/100

Polycyclo ring system having the hetero ring as one of the cyclos

174
514/101

Two or more oxygen in the hetero ring

38
514/109

P-x-x containing (x is chalcogen)

66
514/139

Phosphorus bonded directly to halogen

23
514/110

Phosphorus is part of a ring

153
514/111

Polycyclo ring system having the phosphorus containing ring as one of the cyclos

15
514/95

Sulfur containing hetero ring

120
514/98

Oxygen in the hetero ring

17
514/96

Polycyclo ring system having the hetero ring as one of the cyclos

46
514/97

Two or more sulfurs in the hetero ring

24
514/126

Sulfur not bonded directly to phosphorus

49
514/127

Thioether, sulfoxide or sulfone

82
514/128

Sulfur bonded directly to a benzene ring

79
514/102

Two or more phosphorus atoms directly or indirectly bonded together by only covalent bonds

181
514/108

Acyclic and contains at least one carbon atom between the phosphorus atoms

221
514/107

Benzene ring containing

120
514/106

P-o-p or p-s-p containing (e.g., anhydrides, etc.)

32
514/103

Phosphorus acid ester of polyhydric alcohol or thioalcohol (e.g., p-x-r-x-p group, etc., wherein x is chalcogen and r is the residue of the polyhydric alcohol or thioalcohol)

89
514/104

Benzene ring in the alcohol moiety

32
514/105

Phosphorus is part of a ring

41
514/65

Pyrethrum plant derived material or plant derived rotenone compound containing doai

96
514/68

With carboxylic acid ester

32
514/69

With carboxylic acid metal salt

15
514/66

With heterocyclic compound

24
514/67

Methylenedioxyphenyl group containing (e.g., piperonyl butoxide, etc.)

18
514/74

With hydrocarbon or halohydrocarbon

11
514/70

With organic nitrogen containing compound

22
514/71

Sulfur containing organic nitrogen compound

15
514/72

With organic oxygen containing compound

30
514/73

Phosphorus or halogen containing organic oxygen compound

20
514/553

Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai

295
514/578

Acyclic acid or salt thereof

249
514/554

Amine addition salt of the acid

253
514/555

Benzene ring in acid moiety

138
514/576

Benzene ring containing

223
514/577

Polycyclo ring system

113
514/557

Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.)

1584
514/568

Benzene ring nonionically bonded

631
514/570

Carboxy or salt thereof only attached indirectly to the benzene ring

754
514/571

Ether oxygen single bonded to carboxylic acid, percarboxylic acid or salt thereof through an acyclic carbon or acyclic carbon chain

214
514/569

Polycyclo ring system

530
514/572

Cyclic carboxylic acid containing three to five carbons or cyclic percarboxylic acid containing three to five carbons or salt thereof

104
514/573

Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.)

586
514/558

Higher fatty acid or salt thereof

872
514/560

Carbon to carbon unsaturation

910
514/559

Ring containing

346
514/561

Nitrogen other than as nitro or nitroso nonionically bonded

1225
514/567

Benzene ring nonionically bonded

823
514/564

Plural nitrogens nonionically bonded

451
514/565

N-n or n=c(-n)-n containing (e.g., hydrazines, hydrazones, or quanidines, etc.)

385
514/566

Polycarboxylic acid

188
514/563

Rc(=o)n containing (i.e., carboxamide) (r is c or h)

1008
514/562

Sulfur nonionically bonded

970
514/574

Polycarboxylic acid or salt thereof

511
514/575

Hydroxamic acid or salt thereof

259
514/556

Inner quaternary ammonium salt (e.g., betaine, etc.)

282
514/63

Silicon containing doai

1033
514/706

Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.)

247
514/708

Oxygen bonded directly to sulfur (e.g., sulfoxides, etc.)

154
514/709

Plural oxygens bonded directly to the same sulfur (e.g., sulfones, etc.)

248
514/710

Acyclic carbon to carbon unsaturation

90
514/711

Acyclic

97
514/707

Persulfide (e.g., r-s-s-r, etc.)

78
514/712

Thioether

144
514/713

Acyclic carbon to carbon unsaturation

63
514/772

Designated organic nonactive ingredient containing other than hydrocarbon

765
514/772.1

Aftertreated solid synthetic organic polymer (e.g., grafting, blocking, etc.)

319
514/772.2

Polyvinyl alcohol

169
514/777

Carbohydrate or lignin, or derivative

794
514/779

Algin or derivative

189
514/781

Cellulose or derivative

728
514/780

Locust bean gum

86
514/778

Starch or derivative

347
514/785

Carboxylic acid ester

510
514/787

Beeswax

69
514/786

Glyceride

281
514/784

Carboxylic acid or salt thereof

492
514/782

Natural gum or resin

263
514/788

Nitrogen containing

255
514/773

Peptide containing

327
514/776

Albumin or derivative

74
514/775

Casein (milk protein) or derivative

68
514/774

Gelatin or derivative

192
514/783

Plant extract or plant material of undetermined constitution

423
514/772.3

Solid synthetic organic polymer

878
514/772.7

Heterocyclic monomer

108
514/772.4

Polymer from ethylenic monomers only

322
514/772.6

Carboxylic acid containing monomer

266
514/772.5

Heterocyclic monomer

150
514/866

Diabetes

1030
514/867

Diarrhea

206
514/937

Dispersion or emulsion

1385
514/938

Oil-water type

975
514/939

Mineral oil-water type

247
514/943

Higher fatty acid or derivative containing

325
514/942

Organic sulfonate, sulfate or sulfite containing

81
514/941

Polyoxyalkylated compound containing

326
514/940

Quick break type

28
514/868

Distemper

6
514/869

Diuretic

281
514/936

Dmso containing

61
514/870

Edema

145
514/871

Topical

35
514/872

Emesis (motion sickness-nausea)

110
514/873

Emollient

260
514/809

Enkephalin or endorphin or derivatives

140
514/874

Estrogenic agent (noncontraceptive)

70
514/802

Fibrinopeptides, blood-coagulation factors or derivatives

118
514/875

Flea control

50
514/876

Collar type

12
514/945

Foam

230
514/958

For smoking or inhaling

191
514/877

Gallstone

30
 

Gaseous or gas emitting carrier or propellant

 
514/944

Gel

1196
514/878

Geriatrics

65
514/879

Senility

80
514/880

Hair treatment (therapeutic-scalp)

469
514/881

Shampoo

234
514/882

Hemorrhoid preparation

68
514/DIG.1

Ru 486 (i.e., ru 38486, ru 486-6, mifepristone, mifestone, mifegyne, (11b-[4-(n, n-dimethylamino) phenyl]-17a-(prop-1-ynyl)-^ 4,9-estradiene-17b-ol-3-one, (11b,17b)11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl) estra-4,9-dien-3-one)

39
514/883

Hodgkin's disease

29
514/884

Hypoglycemia

71
514/885

Immune response affecting drug

1164
514/886

Inflammation, skin

545
514/887

Topical treatment

669
514/888

Influenza

73
514/889

Interferon inducer

115
514/890

Irritant (e.g., tear gas, etc.)

7
514/891

Kidney stone

51
514/803

Kinin or derivatives

12
514/892

Laxative

93
514/908

Leukemia

345
514/800

Lhrh like

204
 

Liquid carrier, diluent or solvent

 
514/893

Liver disorder

167
514/894

Hepatitis

150
514/950

Macromolecular (other than synthetic resins)

44
514/895

Malaria

94
514/896

Measles

11
514/897

Rubella

6
514/898

Meningitis

14
514/899

Menstrual disorder

112
514/789

Miscellaneous (e.g., hydrocarbons, etc.)

197
 

Mouth treatment

 
514/902

Gingival

159
514/901

Mouthwash

151
514/900

Periodontitis

161
514/903

Multiple sclerosis

186
514/904

Multiple vitamins

131
514/905

With mineral

102
514/906

Muscle relaxant

205
514/907

Muscular dystrophy

29
514/949

Naturally derived clay (e.g., bentonite, etc.)

75
514/909

Obesity

334
514/910

Anorectic

97
514/911

Bulking agent

34
514/969

Ointment or salve base

371
514/912

Ophthalmic

1056
514/913

Glaucoma

472
514/914

Inflammation

191
514/915

Wetting agent

103
514/807

Oxytoxin, vasopressin or derivatives

62
514/946

Penetrant or absorbent (enhances penetration into subject treated)

399
514/947

Topical application

519
514/804

Phecmycin series or derivatives

5
 

Pill, lozenge, tablet or capsule

 
514/951

Powders, granules or particles of specified mesh or particle size

497
514/952

Wettable

112
514/916

Pyretic

138
514/917

Radioactive, anti-

35
514/966

Rectal

148
514/918

Repellent

79
514/919

Insect

351
514/920

Mammal

80
514/953

Shaped forms adapted for noningestible use other than suppository type (e.g., films, inserts, etc.)

171
514/956

Aural or otic (i.e., ear)

14
514/954

Ocular

36
514/955

Biodegradable type

32
514/921

Shock

140
514/922

Side effect reduction by incorporation of a second designated ingredient

243
514/960

Significant, tablet formulation (e.g., designated excipient, disintegrant, glydent or lubricant, etc.)

472
514/961

Binder therefor

71
514/923

Sleep aid (insomnia)

96
514/948

Solid candy type

78
 

Solid carrier or solid diluent

 
514/788.1

Solid synthetic organic polymer derived solely from hydrocarbon reactants as designated organic nonactive ingredient containing

33
514/806

Somatostatin or derivatives

127
 

Special designated ingredient

 
 

Suppository, bougie or base

 
514/964

Sustained or differential release type

328
514/965

Discrete particles in supporting matrix

301
514/924

Tuberculosis

50
514/925

Ulcer treatment

354
514/926

Duodenal

277
514/927

Peptic

375
514/928

Topical

126
514/968

Urethral

42
514/935

Uterine motility

41
514/967

Vaginal

170
514/957

Vapor emmitting composition

79
514/930

Vasoconstrictor (nondecongestant)

60
514/929

Vasodilator

426
514/931

Veneral disease

80
514/932

Gonorrhea

19
514/933

Syphilis

14
514/934

Virus

286
 
 
  Recently Added Patents
Roll of continuous web of optical film laminate and production method therefor
Formulations, their use as or for producing dishwashing detergents and their production
High dynamic range pixel structure
Acceleration based mode switch
Liquid crystal display device
LED illumination systems
Context-based adaptive binary arithmetic coding engine
  Randomly Featured Patents
Semiconductor structure and method of manufacture
Single logical network interface for advanced load balancing and fail-over functionality
Method of producing surface features in sheet metal using superplastic forming
Method for separating a minute sample from a work piece
Magnetic core for a signal line filter
Method of stencil printing a substrate with foam
Method and apparatus for forming multicolor registered images on edible pieces
Polyacetal resin composition
Galectin recognized photosensitizers for photodynamic therapy
Lumbar support device